Evaluatıon of the Effect of Pulpotomy Treatments Wıth Dıfferent Bıomaterıals on Postoperatıve Paın In Permanent Molars
Launched by TC ERCIYES UNIVERSITY · Jan 17, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different treatments for tooth pulp, specifically partial and total pulpotomy using two materials (BIO MTA+ and Well Root PT), affect pain levels in permanent molars that have been damaged by deep cavities. The goal is to see which treatment helps patients feel better after the procedure and keeps the tooth alive and healthy.
To be eligible for this trial, participants must be adults over 18 years old with healthy teeth that can be restored. Specifically, they should have first or second molars in the lower jaw that have deep cavities and react positively to sensitivity tests. However, people with certain health conditions, severely damaged teeth, or specific dental issues may not qualify. Those who participate can expect to receive one of the two treatments and will be monitored for pain and tooth health afterward. This trial is not yet recruiting participants, but it aims to provide valuable insights into the best ways to treat acute pulpitis, which is an inflammation of the tooth pulp.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 18 years of age with no significant health problems.
- • Restorable and periodontally healthy teeth.
- • Teeth with complete root development.
- • Teeth with cold sensitivity and positive response to electric pulp testing.
- • Lower jaw first and second molars with deep/extremely deep caries detected on periapical radiographs.
- Exclusion Criteria:
- • Patients with systemic diseases or allergic reactions
- • Teeth with open apex
- • Carious teeth that do not respond to pulp sensitivity tests
- • Teeth without signs of bleeding after opening the pulp chamber.
- • Detection of periodontal pockets with a depth greater than 4 mm.
- • Teeth with suspected cracks or crown fractures.
- • Severely damaged teeth
- • Teeth whose bleeding cannot be controlledTeeth with open apex
About Tc Erciyes University
TC Erciyes University is a leading academic institution in Turkey, dedicated to advancing medical research and healthcare through innovative clinical trials. With a strong emphasis on scientific excellence and collaboration, the university leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies aimed at improving patient outcomes. Committed to ethical standards and regulatory compliance, TC Erciyes University fosters a research environment that promotes the development of new therapies and interventions, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kayseri, Melikgazi, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported